
The company was established in Asia in Hong Kong. The main department of described Corporate Investor is located in the Central.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the China Orient Asset Management (International) Holding, startups are often financed by Tencent Holdings, PA Grand Opportunity, JD.com. The meaningful sponsors for the fund in investment in the same round are ZZ Capital, Wei Wang, Vivo Capital. In the next rounds fund is usually obtained by Huajin Capital, Highlight Capital, FTZ Fund.
Opposing the other organizations, this China Orient Asset Management (International) Holding works on 21 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2013. The usual things for fund are deals in the range of more than 100 millions dollars.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Consulting. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Yixin Capital, FreeBorders, Suzhou Kintor Pharmaceuticals.
Related Funds
Fund Name | Location |
94Bits | - |
AV Partners | - |
BMW Innovation Lab | Farnborough, Hampshire, United Kingdom |
Chuxin Capital | Beijing, Beijing, China |
Excel Venture Management | Boston, Massachusetts, United States |
Founder Securities | Changsha, China, Jiangsu |
Hongfan Capital | - |
Maxula Seed Fund | Gabès, Tunis, Tunisia |
Prime Investments | Bethesda, Maryland, United States |
Propeller Inc. | Amman, Amman, Jordan |
QS Capital | China, Fujian, Xiamen |
Sacramento Angels | California, Sacramento, United States |
Seoul Business Agency | Seoul, Seoul-t'ukpyolsi, South Korea |
TMS Entertainment | - |
Wincove | Boston, Massachusetts, United States |
XPV Water Partners | Canada, Ontario, Toronto |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Jiumaojiu | $55M | 30 Dec 2019 | Guangdong Province | ||
Suzhou Kintor Pharmaceuticals | $44M | 12 Jan 2018 | Jiangsu | ||
Yixin Capital | $618M | 12 May 2017 | Shanghai, China | ||
Angiotech Pharmaceuticals | 21 Mar 2017 | British Columbia | |||
FreeBorders | $25M | 08 Nov 2000 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Jiumaojiu | $55M | 30 Dec 2019 | Guangdong Province | ||
Suzhou Kintor Pharmaceuticals | $44M | 12 Jan 2018 | Jiangsu | ||
Yixin Capital | $618M | 12 May 2017 | Shanghai, China | ||
Angiotech Pharmaceuticals | 21 Mar 2017 | British Columbia | |||
FreeBorders | $25M | 08 Nov 2000 | San Francisco, California, United States |